ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression

Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exos...

Full description

Saved in:
Bibliographic Details
Published inDevelopmental cell Vol. 57; no. 3; pp. 329 - 343.e7
Main Authors Zhang, Wei, Zhong, Wenqun, Wang, Beike, Yang, Jiegang, Yang, Jingbo, Yu, Ziyan, Qin, Zhiyuan, Shi, Alex, Xu, Wei, Zheng, Cathy, Schuchter, Lynn M., Karakousis, Giorgos C., Mitchell, Tara C., Amaravadi, Ravi, Herlyn, Meenhard, Dong, Haidong, Gimotty, Phyllis A., Daaboul, George, Xu, Xiaowei, Guo, Wei
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 07.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression. [Display omitted] •ICAM-1 and PD-L1 co-localize on exosomes and are both upregulated by interferon-γ•ICAM-1 is a prerequisite for exosomal PD-L1-mediated inhibition of CD8+ T cells•Reciprocal upregulation of ICAM-1 and LFA-1 promotes exosome-T cell interaction•Established an assay system for the interaction of exosomal PD-L1 with PD-1 on T cells Tumor-derived exosomes can suppress the proliferation and cytotoxicity of CD8+ T cells. Zhang and colleagues report that the exosomes adhere to activated CD8 T cells through an ICAM-1-LFA-1 interaction, which is a prerequisite for exosomal PD-L1-PD-1 binding and T cell suppression.
AbstractList Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression. [Display omitted] •ICAM-1 and PD-L1 co-localize on exosomes and are both upregulated by interferon-γ•ICAM-1 is a prerequisite for exosomal PD-L1-mediated inhibition of CD8+ T cells•Reciprocal upregulation of ICAM-1 and LFA-1 promotes exosome-T cell interaction•Established an assay system for the interaction of exosomal PD-L1 with PD-1 on T cells Tumor-derived exosomes can suppress the proliferation and cytotoxicity of CD8+ T cells. Zhang and colleagues report that the exosomes adhere to activated CD8 T cells through an ICAM-1-LFA-1 interaction, which is a prerequisite for exosomal PD-L1-PD-1 binding and T cell suppression.
Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8 + T cells, thereby contributing to tumor immune evasion. Here we report that the adhesion molecule ICAM-1 co-localizes with PD-L1 on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated on activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8 + T cells, and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an E xtracellular vesicle- T arget cell I nteraction D etection through S orTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with PD-1 on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1 mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1 mediated immune suppression. Tumor-derived exosomes can suppress the proliferation and cytotoxicity of CD8+ T cells. Zhang and colleagues report that the exosomes adhere to activated CD8 T cells through an ICAM-1-LFA-1 interaction, which is a prerequisite for exosomal PD-L1-PD-1 binding and T cell suppression.
Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression.Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8+ T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression.
Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8 T cells, thereby contributing to tumor immune evasion. Here, we report that the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) co-localizes with programmed death ligand 1 (PD-L1) on the exosomes; both ICAM-1 and PD-L1 are upregulated by interferon-γ. Exosomal ICAM-1 interacts with LFA-1, which is upregulated in activated T cells. Blocking ICAM-1 on TEVs reduces the interaction of TEVs with CD8 T cells and attenuates PD-L1-mediated suppressive effects of TEVs. During this study, we have established an extracellular vesicle-target cell interaction detection through SorTagging (ETIDS) system to assess the interaction between a TEV ligand and its target cell receptor. Using this system, we demonstrate that the interaction of TEV PD-L1 with programmed cell death 1 (PD-1) on T cells is significantly reduced in the absence of ICAM-1. Our study demonstrates that ICAM-1-LFA-1-mediated adhesion between TEVs and T cells is a prerequisite for exosomal PD-L1-mediated immune suppression.
Author Yu, Ziyan
Zheng, Cathy
Mitchell, Tara C.
Daaboul, George
Yang, Jingbo
Wang, Beike
Zhang, Wei
Shi, Alex
Xu, Wei
Schuchter, Lynn M.
Amaravadi, Ravi
Gimotty, Phyllis A.
Yang, Jiegang
Karakousis, Giorgos C.
Guo, Wei
Zhong, Wenqun
Dong, Haidong
Xu, Xiaowei
Qin, Zhiyuan
Herlyn, Meenhard
AuthorAffiliation 4 Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA
5 Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA19104, USA
9 Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA
6 Departments of Urology and Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
7 Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA 19104, USA
3 Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA
8 NanoView Biosciences, Inc., Boston, MA 02135, USA
2 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA
1 Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA19104, USA
AuthorAffiliation_xml – name: 4 Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA
– name: 6 Departments of Urology and Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
– name: 1 Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA19104, USA
– name: 5 Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA19104, USA
– name: 2 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA
– name: 3 Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA
– name: 7 Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA 19104, USA
– name: 8 NanoView Biosciences, Inc., Boston, MA 02135, USA
– name: 9 Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USA
Author_xml – sequence: 1
  givenname: Wei
  surname: Zhang
  fullname: Zhang, Wei
  organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 2
  givenname: Wenqun
  surname: Zhong
  fullname: Zhong, Wenqun
  organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 3
  givenname: Beike
  surname: Wang
  fullname: Wang, Beike
  organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 4
  givenname: Jiegang
  surname: Yang
  fullname: Yang, Jiegang
  organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 5
  givenname: Jingbo
  surname: Yang
  fullname: Yang, Jingbo
  organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 6
  givenname: Ziyan
  surname: Yu
  fullname: Yu, Ziyan
  organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 7
  givenname: Zhiyuan
  surname: Qin
  fullname: Qin, Zhiyuan
  organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 8
  givenname: Alex
  surname: Shi
  fullname: Shi, Alex
  organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 9
  givenname: Wei
  surname: Xu
  fullname: Xu, Wei
  organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 10
  givenname: Cathy
  surname: Zheng
  fullname: Zheng, Cathy
  organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 11
  givenname: Lynn M.
  surname: Schuchter
  fullname: Schuchter, Lynn M.
  organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 12
  givenname: Giorgos C.
  surname: Karakousis
  fullname: Karakousis, Giorgos C.
  organization: Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 13
  givenname: Tara C.
  surname: Mitchell
  fullname: Mitchell, Tara C.
  organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 14
  givenname: Ravi
  surname: Amaravadi
  fullname: Amaravadi, Ravi
  organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 15
  givenname: Meenhard
  surname: Herlyn
  fullname: Herlyn, Meenhard
  organization: Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA 19104, USA
– sequence: 16
  givenname: Haidong
  surname: Dong
  fullname: Dong, Haidong
  organization: Departments of Urology and Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
– sequence: 17
  givenname: Phyllis A.
  surname: Gimotty
  fullname: Gimotty, Phyllis A.
  organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 18
  givenname: George
  surname: Daaboul
  fullname: Daaboul, George
  organization: NanoView Biosciences, Inc., Boston, MA 02135, USA
– sequence: 19
  givenname: Xiaowei
  surname: Xu
  fullname: Xu, Xiaowei
  organization: Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
– sequence: 20
  givenname: Wei
  surname: Guo
  fullname: Guo, Wei
  email: guowei@sas.upenn.edu
  organization: Department of Biology, School of Arts & Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35085484$$D View this record in MEDLINE/PubMed
BookMark eNp9Uctu2zAQJAoHjZ30D4JCx1yk8q31pUBgpA_AQYDAd4ISVwkNW3RIyUj-Jt_SLysNp2l7yYkLcGZ2dmZGJn3okZALRitGmf6yrhzuW9xUnHJeUVZRyj-QKYMaSqYUm-RZCVkqoPUpmaW0ppnGgH4kp0JRUBLklNz9XFzdlKzcovN2QFdY94DJh77wqbDFLmLEx9EnP2DRhVjgU0hhi6Xv3dhm-OrXS_awKdK4y9h0YJ6Tk85uEn56fc_I6tv1avGjXN5-z9uWZSu1GEo5b2plXS3nqoHs0TpuNZW10i10qBuGGrTlwEFwJZtONwIEKqdZI5DV4ox8Pcruxia7b7Efot2YXfRbG59NsN78_9P7B3Mf9gYAWD2fZ4HLV4EYHkdMg9n6dDjG9hjGZLjmAkBQBhkqj9A2hpQidm9rGDWHNszaHNswhzYMZSa3kWmf_7X4RvoT_98bMOe09xhNaj32OVgfsR2MC_79Db8BgTCgPg
CitedBy_id crossref_primary_10_1038_s41467_023_36892_4
crossref_primary_10_3389_fcell_2023_1228624
crossref_primary_10_1038_s41419_023_05647_w
crossref_primary_10_1038_s41698_022_00287_3
crossref_primary_10_3389_fimmu_2022_958360
crossref_primary_10_1007_s12013_024_01340_7
crossref_primary_10_1515_med_2024_0969
crossref_primary_10_3390_cells13040339
crossref_primary_10_1038_s41598_022_25811_0
crossref_primary_10_1002_advs_202303230
crossref_primary_10_1016_j_gendis_2023_04_007
crossref_primary_10_1016_j_tcb_2023_06_006
crossref_primary_10_1186_s12964_023_01236_8
crossref_primary_10_1111_cas_15532
crossref_primary_10_1038_s41467_024_48200_9
crossref_primary_10_1158_2326_6066_CIR_22_0277
crossref_primary_10_3390_vaccines10101691
crossref_primary_10_1016_j_phrs_2024_107179
crossref_primary_10_1016_j_phrs_2022_106364
crossref_primary_10_1186_s12964_024_01521_0
crossref_primary_10_1016_j_prp_2024_155288
crossref_primary_10_1038_s41467_023_40850_5
crossref_primary_10_1093_cei_uxae026
crossref_primary_10_1016_j_ymthe_2023_06_005
crossref_primary_10_1152_ajplung_00244_2023
crossref_primary_10_1016_j_trecan_2022_05_002
crossref_primary_10_3389_fonc_2023_1135122
crossref_primary_10_1016_j_bbcan_2023_188908
crossref_primary_10_1002_advs_202404064
crossref_primary_10_1007_s10555_024_10189_4
crossref_primary_10_1002_smll_202301019
crossref_primary_10_1158_0008_5472_CAN_22_2220
crossref_primary_10_3389_fcimb_2023_1240516
crossref_primary_10_1038_s41416_023_02369_w
crossref_primary_10_3390_cancers15041097
crossref_primary_10_3389_fimmu_2024_1395332
crossref_primary_10_1007_s13659_023_00375_2
crossref_primary_10_3390_ijms232112971
crossref_primary_10_1002_jev2_12322
crossref_primary_10_1111_nyas_14974
crossref_primary_10_1073_pnas_2210047120
crossref_primary_10_1186_s13287_023_03594_z
crossref_primary_10_1007_s00262_023_03562_9
crossref_primary_10_3389_fimmu_2022_1002551
crossref_primary_10_1021_acs_analchem_2c03725
crossref_primary_10_1126_sciadv_adg1082
crossref_primary_10_3389_fimmu_2024_1376962
crossref_primary_10_3390_cells12081136
crossref_primary_10_1016_j_drup_2024_101112
crossref_primary_10_3390_ijms24020965
crossref_primary_10_3390_ijms25063449
Cites_doi 10.1038/nature21349
10.1038/nm730
10.5772/61186
10.1016/j.cell.2016.01.043
10.1126/science.aau6977
10.4161/onci.23972
10.3389/fimmu.2018.00952
10.1038/nature25442
10.1146/annurev-immunol-032414-112049
10.1038/s41422-018-0060-4
10.1016/j.celrep.2018.06.066
10.1074/jbc.M116.763888
10.1016/j.bbrc.2010.05.094
10.1158/0008-5472.CAN-08-0719
10.1158/1078-0432.CCR-17-2664
10.1080/2162402X.2016.1261243
10.3389/fimmu.2018.00847
10.1016/j.cell.2019.02.016
10.1245/s10434-019-07431-7
10.1158/0008-5472.CAN-12-2569
10.1158/2159-8290.CD-18-0367
10.1159/000053691
10.1111/j.1346-8138.1997.tb02805.x
10.1038/nmeth.3047
10.1182/blood-2008-08-174094
10.3389/fimmu.2019.01078
10.3389/fcell.2018.00018
10.1016/j.cell.2017.01.017
10.1016/j.cub.2012.01.028
10.1126/sciadv.aar2766
10.1038/nature15756
10.1186/ar559
10.1182/blood-2004-03-0824
10.1146/annurev-cellbio-101512-122326
10.1016/j.ijrobp.2018.09.001
10.1038/s41586-018-0392-8
10.1016/j.semcdb.2017.08.022
10.1126/science.aar4060
10.4049/jimmunol.130.4.1784
10.4049/jimmunol.161.8.4016
10.1038/nmeth.2019
10.1111/pcmr.12498
10.1093/nar/gks1215
10.3349/ymj.1995.36.1.15
10.1111/j.1365-2567.2008.02888.x
10.1016/j.immuni.2019.12.011
10.1016/j.trecan.2020.03.002
10.1182/blood-2005-01-0220
10.1186/s12967-019-2101-2
10.1152/ajpcell.00228.2013
10.1038/ncb2000
ContentType Journal Article
Copyright 2022 Elsevier Inc.
Copyright © 2022 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2022 Elsevier Inc.
– notice: Copyright © 2022 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1016/j.devcel.2022.01.002
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1878-1551
EndPage 343.e7
ExternalDocumentID 10_1016_j_devcel_2022_01_002
35085484
S1534580722000028
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: P50 CA261608
– fundername: NCI NIH HHS
  grantid: P30 CA010815
– fundername: NIGMS NIH HHS
  grantid: R35 GM141832
– fundername: NCI NIH HHS
  grantid: P50 CA174523
– fundername: NCI NIH HHS
  grantid: U01 CA250044
GroupedDBID ---
--K
0R~
1~5
2WC
4.4
457
4G.
5GY
62-
7-5
AACTN
AAEDW
AAFTH
AAIAV
AAKRW
AALRI
AAUCE
AAVLU
AAXUO
ABJNI
ABMAC
ABMWF
ABVKL
ACGFO
ACGFS
ACNCT
ADBBV
ADEZE
ADJPV
AEFWE
AENEX
AEXQZ
AFFNX
AFTJW
AGKMS
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BAWUL
CS3
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FCP
FDB
FEDTE
FIRID
HVGLF
IHE
IXB
J1W
JIG
M3Z
M41
O-L
O9-
OK1
P2P
RCE
ROL
RPZ
SDG
SES
SSZ
TR2
WQ6
ZA5
0SF
AAEDT
AAMRU
ADVLN
AKAPO
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
RIG
29F
53G
5VS
6I.
AAIKJ
AAQFI
AAQXK
AAYXX
ADMUD
AGHFR
CITATION
FGOYB
HZ~
NCXOZ
OZT
R2-
UHS
7X8
5PM
ID FETCH-LOGICAL-c463t-49b75ad7495b8807ad2a604756c8fe6b1e686a28283254bf6b383e5d61b3e173
IEDL.DBID ABVKL
ISSN 1534-5807
1878-1551
IngestDate Tue Sep 17 21:30:31 EDT 2024
Sat Oct 26 04:19:09 EDT 2024
Thu Sep 26 17:50:40 EDT 2024
Sat Nov 02 12:09:15 EDT 2024
Fri Feb 23 02:43:58 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords PD-L1
CD8+ T cells
ICAM-1
extracellular vesicles
immune suppression
exosome
CD8(+) T cells
Language English
License Copyright © 2022 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c463t-49b75ad7495b8807ad2a604756c8fe6b1e686a28283254bf6b383e5d61b3e173
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Wei Zhang and Wenqun Zhong contributed equally to this work.
W.Z. and W.G. conceived the project and designed the experiments. W.Z., W.Zho., B.W., and Jie.Y. purified and characterized extracellular vesicles. W.Z., W.Zho., B.W., Jie.Y., Jin.Y. and Z.Y. performed the mice experiments. W.Z. and W.Zho. established knockdown and knockout cell lines, collected exosomes and performed the T cell binding assays, the T cell proliferation and activation assays. W.Z., W. Zho. and Z.Q. performed ELISA assays. W.Z., W. Zho. and B.W. performed the nanoparticle tracking analysis. W.Z., W. Zho., B.W., Jie.Y. and A.S. performed the immunoprecipitation and western blot analysis. W.Z. established EDITS system and tested the exosomal PD-L1/PD-1 interaction. W. Zho performed immune-TEM and ICAM-1+ exosome depletion assays. W.Z., W.Zho. and Jin. Y. performed the flow cytometry experiments. X.X. performed pathological analyses. W.X., C.Z., L.M.S., G.C.K., T.C.M. and R.A. provided human samples and associated clinical data. M.H., and H.D. provided antibodies and cell lines. W.Z., W.Zho., B.W., Jie.Y. analyzed and interpreted the data. W.Z. and P.A.G. performed the statistical analysis. W.Z., W.Zho. and W.G. wrote the paper. A.S., W.X., R.A. and X.X. edited the paper. All authors have read and approved the final manuscript.
Lead contact
Author contributions
OpenAccessLink https://doi.org/10.1016/j.devcel.2022.01.002
PMID 35085484
PQID 2623883018
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8881799
proquest_miscellaneous_2623883018
crossref_primary_10_1016_j_devcel_2022_01_002
pubmed_primary_35085484
elsevier_sciencedirect_doi_10_1016_j_devcel_2022_01_002
PublicationCentury 2000
PublicationDate 2022-02-07
PublicationDateYYYYMMDD 2022-02-07
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-02-07
  day: 07
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Developmental cell
PublicationTitleAlternate Dev Cell
PublicationYear 2022
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Hegde, Chen (bib13) 2020; 52
Schindelin, Arganda-Carreras, Frise, Kaynig, Longair, Pietzsch, Preibisch, Rueden, Saalfeld, Schmid (bib41) 2012; 9
Li, Li, Zhi, Liang, Wang, Chen, Lv, Shen, Song, Lin, Liu (bib21) 2019; 17
Meeth, Wang, Micevic, Damsky, Bosenberg (bib27) 2016; 29
Dong, Strome, Salomao, Tamura, Hirano, Flies, Roche, Lu, Zhu, Tamada (bib6) 2002; 8
Markel, Seidman, Cohen, Besser, Sinai, Treves, Orenstein, Berger, Schachter (bib25) 2009; 126
Tominaga, Kita, Satoh, Asai, Kato, Ishikawa, Horiuchi, Takashi (bib48) 1998; 161
Turturici, Tinnirello, Sconzo, Geraci (bib49) 2014; 306
Evans, Morris, Zhang, Cao, Liu, Mara, Stish, Davis, Mansfield, Dronca (bib8) 2019; 103
Hoshino, Costa-Silva, Shen, Rodrigues, Hashimoto, Tesic Mark, Molina, Kohsaka, Di Giannatale, Ceder (bib14) 2015; 527
Franciszkiewicz, Le Floc'h, Boutet, Vergnon, Schmitt, Mami-Chouaib (bib10) 2013; 73
Segura, Nicco, Lombard, Véron, Raposo, Batteux, Amigorena, Théry (bib43) 2005; 106
Nakayama, Guan, Nakashima, Mashino, Hori (bib32) 1997; 24
Pasqual, Chudnovskiy, Tas, Agudelo, Schweitzer, Cui, Hacohen, Victora (bib35) 2018; 553
Sharma, Hu-Lieskovan, Wargo, Ribas (bib44) 2017; 168
Ricklefs, Alayo, Krenzlin, Mahmoud, Speranza, Nakashima, Hayes, Lee, Balaj, Passaro (bib38) 2018; 4
Theodoraki, Yerneni, Hoffmann, Gooding, Whiteside (bib46) 2018; 24
Castro, Cardoso, Gonçalves, Serre, Oliveira (bib2) 2018; 9
Li, Cheng, Tilevik, Davis, Zhu (bib22) 2017; 292
Baumeister, Freeman, Dranoff, Sharpe (bib1) 2016; 34
Nolte-'t Hoen, Buschow, Anderton, Stoorvogel, Wauben (bib33) 2009; 113
Ribas, Wolchok (bib37) 2018; 359
Juan, Fürthauer (bib15) 2018; 74
Yang, Li, Chan, Wei, Hsu, Xia, Cha, Hou, Hsu, Sun (bib52) 2018; 28
Monypenny, Milewicz, Flores-Borja, Weitsman, Cheung, Chowdhury, Burgoyne, Arulappu, Lawler, Barber (bib28) 2018; 24
Maia, Caja, Strano Moraes, Couto, Costa-Silva (bib24) 2018; 6
Walling, Kim (bib50) 2018; 9
Kim, Lee, Park, Lee, Kim, Kim (bib19) 1995; 36
McKelvey, Powell, Ashton, Morris, McCracken (bib26) 2015; 4
Colombo, Raposo, Théry (bib5) 2014; 30
Wei, Duffy, Allison (bib51) 2018; 8
Fan, Che, Qu, Hou, Wen, Li, Li, Wang, Xu, Liu, Qu (bib9) 2019; 26
Chen, Huang, Zhang, Zhang, Wu, Xu, Yu, Yang, Wang, Sun (bib4) 2018; 560
Kalluri, LeBleu (bib16) 2020; 367
Harjunpää, Llort Asens, Guenther, Fagerholm (bib12) 2019; 10
Muller, Simms, Hong, Nishimura, Jackson, Watkins, Whiteside (bib31) 2017; 6
Tkach, Théry (bib47) 2016; 164
Skokos, Le Panse, Villa, Rousselle, Peronet, Namane, David, Mécheri (bib45) 2001; 124
Rusinova, Forster, Yu, Kannan, Masse, Cumming, Chapman, Hertzog (bib39) 2013; 41
Lee, Choi, Kim, Kim, Kim, Kang, Gho (bib20) 2010; 397
Kasahara, Hooks, Dougherty, Oppenheim (bib17) 1983; 130
Sanjana, Shalem, Zhang (bib40) 2014; 11
Liu, Gibbons, Harrington, Krco, Markovic, Kwon, Dong (bib23) 2013; 2
Dustin (bib7) 2002; 4
Ostrowski, Carmo, Krumeich, Fanget, Raposo, Savina, Moita, Schauer, Hume, Freitas (bib34) 2010; 12
Poggio, Hu, Pai, Chu, Belair, Chang, Montabana, Lang, Fu, Fong, Blelloch (bib36) 2019; 177
Morrissey, Yan (bib30) 2020; 6
Chen, Mellman (bib3) 2017; 541
Morelli, Larregina, Shufesky, Sullivan, Stolz, Papworth, Zahorchak, Logar, Wang, Watkins (bib29) 2004; 104
Hamaï, Meslin, Benlalam, Jalil, Mehrpour, Faure, Lecluse, Vielh, Avril, Robert, Chouaib (bib11) 2008; 68
Schmidt, Teis (bib42) 2012; 22
Kim, Kim, Choi, Kim, Lee, Sung, Sung, Pack, Jung, Han (bib18) 2019; 51
Monypenny (10.1016/j.devcel.2022.01.002_bib28) 2018; 24
Nolte-'t Hoen (10.1016/j.devcel.2022.01.002_bib33) 2009; 113
Harjunpää (10.1016/j.devcel.2022.01.002_bib12) 2019; 10
Chen (10.1016/j.devcel.2022.01.002_bib4) 2018; 560
Sanjana (10.1016/j.devcel.2022.01.002_bib40) 2014; 11
Markel (10.1016/j.devcel.2022.01.002_bib25) 2009; 126
Meeth (10.1016/j.devcel.2022.01.002_bib27) 2016; 29
Turturici (10.1016/j.devcel.2022.01.002_bib49) 2014; 306
Theodoraki (10.1016/j.devcel.2022.01.002_bib46) 2018; 24
Segura (10.1016/j.devcel.2022.01.002_bib43) 2005; 106
Kasahara (10.1016/j.devcel.2022.01.002_bib17) 1983; 130
Wei (10.1016/j.devcel.2022.01.002_bib51) 2018; 8
Maia (10.1016/j.devcel.2022.01.002_bib24) 2018; 6
Sharma (10.1016/j.devcel.2022.01.002_bib44) 2017; 168
Tkach (10.1016/j.devcel.2022.01.002_bib47) 2016; 164
Castro (10.1016/j.devcel.2022.01.002_bib2) 2018; 9
Walling (10.1016/j.devcel.2022.01.002_bib50) 2018; 9
Franciszkiewicz (10.1016/j.devcel.2022.01.002_bib10) 2013; 73
Kalluri (10.1016/j.devcel.2022.01.002_bib16) 2020; 367
Baumeister (10.1016/j.devcel.2022.01.002_bib1) 2016; 34
Ostrowski (10.1016/j.devcel.2022.01.002_bib34) 2010; 12
McKelvey (10.1016/j.devcel.2022.01.002_bib26) 2015; 4
Rusinova (10.1016/j.devcel.2022.01.002_bib39) 2013; 41
Morelli (10.1016/j.devcel.2022.01.002_bib29) 2004; 104
Yang (10.1016/j.devcel.2022.01.002_bib52) 2018; 28
Evans (10.1016/j.devcel.2022.01.002_bib8) 2019; 103
Dong (10.1016/j.devcel.2022.01.002_bib6) 2002; 8
Nakayama (10.1016/j.devcel.2022.01.002_bib32) 1997; 24
Hegde (10.1016/j.devcel.2022.01.002_bib13) 2020; 52
Lee (10.1016/j.devcel.2022.01.002_bib20) 2010; 397
Poggio (10.1016/j.devcel.2022.01.002_bib36) 2019; 177
Tominaga (10.1016/j.devcel.2022.01.002_bib48) 1998; 161
Schmidt (10.1016/j.devcel.2022.01.002_bib42) 2012; 22
Ribas (10.1016/j.devcel.2022.01.002_bib37) 2018; 359
Pasqual (10.1016/j.devcel.2022.01.002_bib35) 2018; 553
Hoshino (10.1016/j.devcel.2022.01.002_bib14) 2015; 527
Kim (10.1016/j.devcel.2022.01.002_bib18) 2019; 51
Morrissey (10.1016/j.devcel.2022.01.002_bib30) 2020; 6
Schindelin (10.1016/j.devcel.2022.01.002_bib41) 2012; 9
Colombo (10.1016/j.devcel.2022.01.002_bib5) 2014; 30
Dustin (10.1016/j.devcel.2022.01.002_bib7) 2002; 4
Kim (10.1016/j.devcel.2022.01.002_bib19) 1995; 36
Skokos (10.1016/j.devcel.2022.01.002_bib45) 2001; 124
Chen (10.1016/j.devcel.2022.01.002_bib3) 2017; 541
Fan (10.1016/j.devcel.2022.01.002_bib9) 2019; 26
Hamaï (10.1016/j.devcel.2022.01.002_bib11) 2008; 68
Juan (10.1016/j.devcel.2022.01.002_bib15) 2018; 74
Li (10.1016/j.devcel.2022.01.002_bib22) 2017; 292
Liu (10.1016/j.devcel.2022.01.002_bib23) 2013; 2
Muller (10.1016/j.devcel.2022.01.002_bib31) 2017; 6
Li (10.1016/j.devcel.2022.01.002_bib21) 2019; 17
Ricklefs (10.1016/j.devcel.2022.01.002_bib38) 2018; 4
References_xml – volume: 103
  start-page: 229
  year: 2019
  end-page: 240
  ident: bib8
  article-title: Prospective immunophenotyping of CD8(+) T cells and associated clinical outcomes of patients with oligometastatic prostate cancer treated with metastasis-directed SBRT
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  contributor:
    fullname: Dronca
– volume: 17
  start-page: 355
  year: 2019
  ident: bib21
  article-title: Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
  publication-title: J. Transl. Med.
  contributor:
    fullname: Liu
– volume: 6
  start-page: e1261243
  year: 2017
  ident: bib31
  article-title: Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms
  publication-title: Oncoimmunology
  contributor:
    fullname: Whiteside
– volume: 113
  start-page: 1977
  year: 2009
  end-page: 1981
  ident: bib33
  article-title: Activated T cells recruit exosomes secreted by dendritic cells via LFA-1
  publication-title: Blood
  contributor:
    fullname: Wauben
– volume: 130
  start-page: 1784
  year: 1983
  end-page: 1789
  ident: bib17
  article-title: Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets
  publication-title: J. Immunol.
  contributor:
    fullname: Oppenheim
– volume: 29
  start-page: 590
  year: 2016
  end-page: 597
  ident: bib27
  article-title: The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations
  publication-title: Pigment Cell Melanoma Res
  contributor:
    fullname: Bosenberg
– volume: 12
  start-page: 19
  year: 2010
  end-page: 30
  ident: bib34
  article-title: Rab27a and Rab27b control different steps of the exosome secretion pathway
  publication-title: Nat. Cell Biol.
  contributor:
    fullname: Freitas
– volume: 24
  start-page: 896
  year: 2018
  end-page: 905
  ident: bib46
  article-title: Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients
  publication-title: Clin. Cancer Res.
  contributor:
    fullname: Whiteside
– volume: 541
  start-page: 321
  year: 2017
  end-page: 330
  ident: bib3
  article-title: Elements of cancer immunity and the cancer-immune set point
  publication-title: Nature
  contributor:
    fullname: Mellman
– volume: 177
  start-page: 414
  year: 2019
  end-page: 427.e13
  ident: bib36
  article-title: Suppression of Exosomal PD-L1 induces systemic anti-tumor immunity and memory
  publication-title: Cell
  contributor:
    fullname: Blelloch
– volume: 527
  start-page: 329
  year: 2015
  end-page: 335
  ident: bib14
  article-title: Tumour exosome integrins determine organotropic metastasis
  publication-title: Nature
  contributor:
    fullname: Ceder
– volume: 24
  start-page: 351
  year: 1997
  end-page: 360
  ident: bib32
  article-title: In vitro comparison between mouse B16 and human melanoma cell lines of the expression of ICAM-1 induced by cytokines and/or hyperthermia
  publication-title: J. Dermatol.
  contributor:
    fullname: Hori
– volume: 397
  start-page: 251
  year: 2010
  end-page: 256
  ident: bib20
  article-title: A membranous form of ICAM-1 on exosomes efficiently blocks leukocyte adhesion to activated endothelial cells
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Gho
– volume: 6
  start-page: 18
  year: 2018
  ident: bib24
  article-title: Exosome-based cell-cell communication in the tumor microenvironment
  publication-title: Front. Cell Dev. Biol.
  contributor:
    fullname: Costa-Silva
– volume: 28
  start-page: 862
  year: 2018
  end-page: 864
  ident: bib52
  article-title: Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth
  publication-title: Cell Res.
  contributor:
    fullname: Sun
– volume: 8
  start-page: 1069
  year: 2018
  end-page: 1086
  ident: bib51
  article-title: Fundamental mechanisms of immune checkpoint blockade therapy
  publication-title: Cancer Discov.
  contributor:
    fullname: Allison
– volume: 11
  start-page: 783
  year: 2014
  end-page: 784
  ident: bib40
  article-title: Improved vectors and genome-wide libraries for CRISPR screening
  publication-title: Nat. Methods
  contributor:
    fullname: Zhang
– volume: 41
  start-page: D1040
  year: 2013
  end-page: D1046
  ident: bib39
  article-title: Interferome v2.0: an updated database of annotated interferon-regulated genes
  publication-title: Nucleic Acids Res.
  contributor:
    fullname: Hertzog
– volume: 9
  start-page: 952
  year: 2018
  ident: bib50
  article-title: LFA-1 in T cell migration and differentiation
  publication-title: Front. Immunol.
  contributor:
    fullname: Kim
– volume: 161
  start-page: 4016
  year: 1998
  end-page: 4022
  ident: bib48
  article-title: Affinity and kinetic analysis of the molecular interaction of ICAM-1 and leukocyte function-associated antigen-1
  publication-title: J. Immunol.
  contributor:
    fullname: Takashi
– volume: 104
  start-page: 3257
  year: 2004
  end-page: 3266
  ident: bib29
  article-title: Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells
  publication-title: Blood
  contributor:
    fullname: Watkins
– volume: 52
  start-page: 17
  year: 2020
  end-page: 35
  ident: bib13
  article-title: Top 10 challenges in cancer immunotherapy
  publication-title: Immunity
  contributor:
    fullname: Chen
– volume: 24
  start-page: 630
  year: 2018
  end-page: 641
  ident: bib28
  article-title: Alix regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation
  publication-title: Cell Rep
  contributor:
    fullname: Barber
– volume: 106
  start-page: 216
  year: 2005
  end-page: 223
  ident: bib43
  article-title: ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming
  publication-title: Blood
  contributor:
    fullname: Théry
– volume: 51
  start-page: 1
  year: 2019
  end-page: 13
  ident: bib18
  article-title: Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
  publication-title: Exp. Mol. Med.
  contributor:
    fullname: Han
– volume: 164
  start-page: 1226
  year: 2016
  end-page: 1232
  ident: bib47
  article-title: Communication by extracellular vesicles: where we are and where we need to go
  publication-title: Cell
  contributor:
    fullname: Théry
– volume: 168
  start-page: 707
  year: 2017
  end-page: 723
  ident: bib44
  article-title: Primary, adaptive, and acquired resistance to cancer immunotherapy
  publication-title: Cell
  contributor:
    fullname: Ribas
– volume: 73
  start-page: 617
  year: 2013
  end-page: 628
  ident: bib10
  article-title: CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions
  publication-title: Cancer Res.
  contributor:
    fullname: Mami-Chouaib
– volume: 10
  start-page: 1078
  year: 2019
  ident: bib12
  article-title: Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment
  publication-title: Front. Immunol.
  contributor:
    fullname: Fagerholm
– volume: 34
  start-page: 539
  year: 2016
  end-page: 573
  ident: bib1
  article-title: Coinhibitory pathways in immunotherapy for cancer
  publication-title: Annu. Rev. Immunol.
  contributor:
    fullname: Sharpe
– volume: 9
  start-page: 847
  year: 2018
  ident: bib2
  article-title: Interferon-gamma at the crossroads of tumor immune surveillance or evasion
  publication-title: Front. Immunol.
  contributor:
    fullname: Oliveira
– volume: 359
  start-page: 1350
  year: 2018
  end-page: 1355
  ident: bib37
  article-title: Cancer immunotherapy using checkpoint blockade
  publication-title: Science
  contributor:
    fullname: Wolchok
– volume: 4
  start-page: S119
  year: 2002
  end-page: S125
  ident: bib7
  article-title: The immunological synapse
  publication-title: Arthritis Res
  contributor:
    fullname: Dustin
– volume: 9
  start-page: 676
  year: 2012
  end-page: 682
  ident: bib41
  article-title: Fiji: an open-source platform for biological-image analysis
  publication-title: Nat. Methods
  contributor:
    fullname: Schmid
– volume: 68
  start-page: 9854
  year: 2008
  end-page: 9864
  ident: bib11
  article-title: ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway
  publication-title: Cancer Res.
  contributor:
    fullname: Chouaib
– volume: 30
  start-page: 255
  year: 2014
  end-page: 289
  ident: bib5
  article-title: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles
  publication-title: Annu. Rev. Cell Dev. Biol.
  contributor:
    fullname: Théry
– volume: 8
  start-page: 793
  year: 2002
  end-page: 800
  ident: bib6
  article-title: Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
  publication-title: Nat. Med.
  contributor:
    fullname: Tamada
– volume: 2
  start-page: e23972
  year: 2013
  ident: bib23
  article-title: Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth
  publication-title: Oncoimmunology
  contributor:
    fullname: Dong
– volume: 4
  start-page: eaar2766
  year: 2018
  ident: bib38
  article-title: Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
  publication-title: Sci. Adv.
  contributor:
    fullname: Passaro
– volume: 124
  start-page: 133
  year: 2001
  end-page: 136
  ident: bib45
  article-title: Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes
  publication-title: Int. Arch. Allergy Immunol.
  contributor:
    fullname: Mécheri
– volume: 306
  start-page: C621
  year: 2014
  end-page: C633
  ident: bib49
  article-title: Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages
  publication-title: Am. J. Physiol. Cell Physiol.
  contributor:
    fullname: Geraci
– volume: 292
  start-page: 6799
  year: 2017
  end-page: 6809
  ident: bib22
  article-title: In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network
  publication-title: J. Biol. Chem.
  contributor:
    fullname: Zhu
– volume: 560
  start-page: 382
  year: 2018
  end-page: 386
  ident: bib4
  article-title: Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
  publication-title: Nature
  contributor:
    fullname: Sun
– volume: 4
  start-page: 7
  year: 2015
  ident: bib26
  article-title: Exosomes: mechanisms of uptake
  publication-title: J. Circ. Biomark.
  contributor:
    fullname: McCracken
– volume: 26
  start-page: 3745
  year: 2019
  end-page: 3755
  ident: bib9
  article-title: Exosomal PD-L1 retains immunosuppressive activity and is associated with gastric cancer prognosis
  publication-title: Ann. Surg. Oncol.
  contributor:
    fullname: Qu
– volume: 126
  start-page: 186
  year: 2009
  end-page: 200
  ident: bib25
  article-title: Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack
  publication-title: Immunology
  contributor:
    fullname: Schachter
– volume: 367
  year: 2020
  ident: bib16
  article-title: The biology, function, and biomedical applications of exosomes
  publication-title: Science
  contributor:
    fullname: LeBleu
– volume: 74
  start-page: 66
  year: 2018
  end-page: 77
  ident: bib15
  article-title: Biogenesis and function of ESCRT-dependent extracellular vesicles
  publication-title: Semin. Cell Dev. Biol.
  contributor:
    fullname: Fürthauer
– volume: 6
  start-page: 550
  year: 2020
  end-page: 558
  ident: bib30
  article-title: Exosomal PD-L1: roles in tumor progression and immunotherapy
  publication-title: Trends Cancer
  contributor:
    fullname: Yan
– volume: 553
  start-page: 496
  year: 2018
  end-page: 500
  ident: bib35
  article-title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling
  publication-title: Nature
  contributor:
    fullname: Victora
– volume: 36
  start-page: 15
  year: 1995
  end-page: 25
  ident: bib19
  article-title: Induction of ICAM-1 and HLA-DR expression by IFN-gamma in malignant melanoma cell lines
  publication-title: Yonsei Med. J.
  contributor:
    fullname: Kim
– volume: 22
  start-page: R116
  year: 2012
  end-page: R120
  ident: bib42
  article-title: The ESCRT machinery
  publication-title: Curr. Biol.
  contributor:
    fullname: Teis
– volume: 541
  start-page: 321
  year: 2017
  ident: 10.1016/j.devcel.2022.01.002_bib3
  article-title: Elements of cancer immunity and the cancer-immune set point
  publication-title: Nature
  doi: 10.1038/nature21349
  contributor:
    fullname: Chen
– volume: 8
  start-page: 793
  year: 2002
  ident: 10.1016/j.devcel.2022.01.002_bib6
  article-title: Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
  publication-title: Nat. Med.
  doi: 10.1038/nm730
  contributor:
    fullname: Dong
– volume: 4
  start-page: 7
  year: 2015
  ident: 10.1016/j.devcel.2022.01.002_bib26
  article-title: Exosomes: mechanisms of uptake
  publication-title: J. Circ. Biomark.
  doi: 10.5772/61186
  contributor:
    fullname: McKelvey
– volume: 164
  start-page: 1226
  year: 2016
  ident: 10.1016/j.devcel.2022.01.002_bib47
  article-title: Communication by extracellular vesicles: where we are and where we need to go
  publication-title: Cell
  doi: 10.1016/j.cell.2016.01.043
  contributor:
    fullname: Tkach
– volume: 367
  year: 2020
  ident: 10.1016/j.devcel.2022.01.002_bib16
  article-title: The biology, function, and biomedical applications of exosomes
  publication-title: Science
  doi: 10.1126/science.aau6977
  contributor:
    fullname: Kalluri
– volume: 2
  start-page: e23972
  year: 2013
  ident: 10.1016/j.devcel.2022.01.002_bib23
  article-title: Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth
  publication-title: Oncoimmunology
  doi: 10.4161/onci.23972
  contributor:
    fullname: Liu
– volume: 9
  start-page: 952
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib50
  article-title: LFA-1 in T cell migration and differentiation
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.00952
  contributor:
    fullname: Walling
– volume: 553
  start-page: 496
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib35
  article-title: Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling
  publication-title: Nature
  doi: 10.1038/nature25442
  contributor:
    fullname: Pasqual
– volume: 34
  start-page: 539
  year: 2016
  ident: 10.1016/j.devcel.2022.01.002_bib1
  article-title: Coinhibitory pathways in immunotherapy for cancer
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev-immunol-032414-112049
  contributor:
    fullname: Baumeister
– volume: 28
  start-page: 862
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib52
  article-title: Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth
  publication-title: Cell Res.
  doi: 10.1038/s41422-018-0060-4
  contributor:
    fullname: Yang
– volume: 24
  start-page: 630
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib28
  article-title: Alix regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2018.06.066
  contributor:
    fullname: Monypenny
– volume: 292
  start-page: 6799
  year: 2017
  ident: 10.1016/j.devcel.2022.01.002_bib22
  article-title: In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M116.763888
  contributor:
    fullname: Li
– volume: 397
  start-page: 251
  year: 2010
  ident: 10.1016/j.devcel.2022.01.002_bib20
  article-title: A membranous form of ICAM-1 on exosomes efficiently blocks leukocyte adhesion to activated endothelial cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2010.05.094
  contributor:
    fullname: Lee
– volume: 68
  start-page: 9854
  year: 2008
  ident: 10.1016/j.devcel.2022.01.002_bib11
  article-title: ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-08-0719
  contributor:
    fullname: Hamaï
– volume: 24
  start-page: 896
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib46
  article-title: Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-17-2664
  contributor:
    fullname: Theodoraki
– volume: 6
  start-page: e1261243
  year: 2017
  ident: 10.1016/j.devcel.2022.01.002_bib31
  article-title: Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms
  publication-title: Oncoimmunology
  doi: 10.1080/2162402X.2016.1261243
  contributor:
    fullname: Muller
– volume: 9
  start-page: 847
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib2
  article-title: Interferon-gamma at the crossroads of tumor immune surveillance or evasion
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.00847
  contributor:
    fullname: Castro
– volume: 177
  start-page: 414
  year: 2019
  ident: 10.1016/j.devcel.2022.01.002_bib36
  article-title: Suppression of Exosomal PD-L1 induces systemic anti-tumor immunity and memory
  publication-title: Cell
  doi: 10.1016/j.cell.2019.02.016
  contributor:
    fullname: Poggio
– volume: 26
  start-page: 3745
  year: 2019
  ident: 10.1016/j.devcel.2022.01.002_bib9
  article-title: Exosomal PD-L1 retains immunosuppressive activity and is associated with gastric cancer prognosis
  publication-title: Ann. Surg. Oncol.
  doi: 10.1245/s10434-019-07431-7
  contributor:
    fullname: Fan
– volume: 73
  start-page: 617
  year: 2013
  ident: 10.1016/j.devcel.2022.01.002_bib10
  article-title: CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-12-2569
  contributor:
    fullname: Franciszkiewicz
– volume: 8
  start-page: 1069
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib51
  article-title: Fundamental mechanisms of immune checkpoint blockade therapy
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-18-0367
  contributor:
    fullname: Wei
– volume: 51
  start-page: 1
  year: 2019
  ident: 10.1016/j.devcel.2022.01.002_bib18
  article-title: Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
  publication-title: Exp. Mol. Med.
  contributor:
    fullname: Kim
– volume: 124
  start-page: 133
  year: 2001
  ident: 10.1016/j.devcel.2022.01.002_bib45
  article-title: Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes
  publication-title: Int. Arch. Allergy Immunol.
  doi: 10.1159/000053691
  contributor:
    fullname: Skokos
– volume: 24
  start-page: 351
  year: 1997
  ident: 10.1016/j.devcel.2022.01.002_bib32
  article-title: In vitro comparison between mouse B16 and human melanoma cell lines of the expression of ICAM-1 induced by cytokines and/or hyperthermia
  publication-title: J. Dermatol.
  doi: 10.1111/j.1346-8138.1997.tb02805.x
  contributor:
    fullname: Nakayama
– volume: 11
  start-page: 783
  year: 2014
  ident: 10.1016/j.devcel.2022.01.002_bib40
  article-title: Improved vectors and genome-wide libraries for CRISPR screening
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.3047
  contributor:
    fullname: Sanjana
– volume: 113
  start-page: 1977
  year: 2009
  ident: 10.1016/j.devcel.2022.01.002_bib33
  article-title: Activated T cells recruit exosomes secreted by dendritic cells via LFA-1
  publication-title: Blood
  doi: 10.1182/blood-2008-08-174094
  contributor:
    fullname: Nolte-'t Hoen
– volume: 10
  start-page: 1078
  year: 2019
  ident: 10.1016/j.devcel.2022.01.002_bib12
  article-title: Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01078
  contributor:
    fullname: Harjunpää
– volume: 6
  start-page: 18
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib24
  article-title: Exosome-based cell-cell communication in the tumor microenvironment
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2018.00018
  contributor:
    fullname: Maia
– volume: 168
  start-page: 707
  year: 2017
  ident: 10.1016/j.devcel.2022.01.002_bib44
  article-title: Primary, adaptive, and acquired resistance to cancer immunotherapy
  publication-title: Cell
  doi: 10.1016/j.cell.2017.01.017
  contributor:
    fullname: Sharma
– volume: 22
  start-page: R116
  year: 2012
  ident: 10.1016/j.devcel.2022.01.002_bib42
  article-title: The ESCRT machinery
  publication-title: Curr. Biol.
  doi: 10.1016/j.cub.2012.01.028
  contributor:
    fullname: Schmidt
– volume: 4
  start-page: eaar2766
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib38
  article-title: Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aar2766
  contributor:
    fullname: Ricklefs
– volume: 527
  start-page: 329
  year: 2015
  ident: 10.1016/j.devcel.2022.01.002_bib14
  article-title: Tumour exosome integrins determine organotropic metastasis
  publication-title: Nature
  doi: 10.1038/nature15756
  contributor:
    fullname: Hoshino
– volume: 4
  start-page: S119
  issue: suppl 3
  year: 2002
  ident: 10.1016/j.devcel.2022.01.002_bib7
  article-title: The immunological synapse
  publication-title: Arthritis Res
  doi: 10.1186/ar559
  contributor:
    fullname: Dustin
– volume: 104
  start-page: 3257
  year: 2004
  ident: 10.1016/j.devcel.2022.01.002_bib29
  article-title: Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells
  publication-title: Blood
  doi: 10.1182/blood-2004-03-0824
  contributor:
    fullname: Morelli
– volume: 30
  start-page: 255
  year: 2014
  ident: 10.1016/j.devcel.2022.01.002_bib5
  article-title: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles
  publication-title: Annu. Rev. Cell Dev. Biol.
  doi: 10.1146/annurev-cellbio-101512-122326
  contributor:
    fullname: Colombo
– volume: 103
  start-page: 229
  year: 2019
  ident: 10.1016/j.devcel.2022.01.002_bib8
  article-title: Prospective immunophenotyping of CD8(+) T cells and associated clinical outcomes of patients with oligometastatic prostate cancer treated with metastasis-directed SBRT
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2018.09.001
  contributor:
    fullname: Evans
– volume: 560
  start-page: 382
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib4
  article-title: Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
  publication-title: Nature
  doi: 10.1038/s41586-018-0392-8
  contributor:
    fullname: Chen
– volume: 74
  start-page: 66
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib15
  article-title: Biogenesis and function of ESCRT-dependent extracellular vesicles
  publication-title: Semin. Cell Dev. Biol.
  doi: 10.1016/j.semcdb.2017.08.022
  contributor:
    fullname: Juan
– volume: 359
  start-page: 1350
  year: 2018
  ident: 10.1016/j.devcel.2022.01.002_bib37
  article-title: Cancer immunotherapy using checkpoint blockade
  publication-title: Science
  doi: 10.1126/science.aar4060
  contributor:
    fullname: Ribas
– volume: 130
  start-page: 1784
  year: 1983
  ident: 10.1016/j.devcel.2022.01.002_bib17
  article-title: Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.130.4.1784
  contributor:
    fullname: Kasahara
– volume: 161
  start-page: 4016
  year: 1998
  ident: 10.1016/j.devcel.2022.01.002_bib48
  article-title: Affinity and kinetic analysis of the molecular interaction of ICAM-1 and leukocyte function-associated antigen-1
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.161.8.4016
  contributor:
    fullname: Tominaga
– volume: 9
  start-page: 676
  year: 2012
  ident: 10.1016/j.devcel.2022.01.002_bib41
  article-title: Fiji: an open-source platform for biological-image analysis
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2019
  contributor:
    fullname: Schindelin
– volume: 29
  start-page: 590
  year: 2016
  ident: 10.1016/j.devcel.2022.01.002_bib27
  article-title: The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations
  publication-title: Pigment Cell Melanoma Res
  doi: 10.1111/pcmr.12498
  contributor:
    fullname: Meeth
– volume: 41
  start-page: D1040
  year: 2013
  ident: 10.1016/j.devcel.2022.01.002_bib39
  article-title: Interferome v2.0: an updated database of annotated interferon-regulated genes
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gks1215
  contributor:
    fullname: Rusinova
– volume: 36
  start-page: 15
  year: 1995
  ident: 10.1016/j.devcel.2022.01.002_bib19
  article-title: Induction of ICAM-1 and HLA-DR expression by IFN-gamma in malignant melanoma cell lines
  publication-title: Yonsei Med. J.
  doi: 10.3349/ymj.1995.36.1.15
  contributor:
    fullname: Kim
– volume: 126
  start-page: 186
  year: 2009
  ident: 10.1016/j.devcel.2022.01.002_bib25
  article-title: Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2008.02888.x
  contributor:
    fullname: Markel
– volume: 52
  start-page: 17
  year: 2020
  ident: 10.1016/j.devcel.2022.01.002_bib13
  article-title: Top 10 challenges in cancer immunotherapy
  publication-title: Immunity
  doi: 10.1016/j.immuni.2019.12.011
  contributor:
    fullname: Hegde
– volume: 6
  start-page: 550
  year: 2020
  ident: 10.1016/j.devcel.2022.01.002_bib30
  article-title: Exosomal PD-L1: roles in tumor progression and immunotherapy
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2020.03.002
  contributor:
    fullname: Morrissey
– volume: 106
  start-page: 216
  year: 2005
  ident: 10.1016/j.devcel.2022.01.002_bib43
  article-title: ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming
  publication-title: Blood
  doi: 10.1182/blood-2005-01-0220
  contributor:
    fullname: Segura
– volume: 17
  start-page: 355
  year: 2019
  ident: 10.1016/j.devcel.2022.01.002_bib21
  article-title: Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-019-2101-2
  contributor:
    fullname: Li
– volume: 306
  start-page: C621
  year: 2014
  ident: 10.1016/j.devcel.2022.01.002_bib49
  article-title: Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages
  publication-title: Am. J. Physiol. Cell Physiol.
  doi: 10.1152/ajpcell.00228.2013
  contributor:
    fullname: Turturici
– volume: 12
  start-page: 19
  year: 2010
  ident: 10.1016/j.devcel.2022.01.002_bib34
  article-title: Rab27a and Rab27b control different steps of the exosome secretion pathway
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb2000
  contributor:
    fullname: Ostrowski
SSID ssj0016180
Score 2.6273406
Snippet Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we...
Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8 T cells, thereby contributing to tumor immune evasion. Here, we...
Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8+ T cells, thereby contributing to tumor immune evasion. Here, we...
Tumor-derived extracellular vesicles (TEVs) suppress the proliferation and cytotoxicity of CD8 + T cells, thereby contributing to tumor immune evasion. Here we...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 329
SubjectTerms Animals
B7-H1 Antigen - metabolism
CD8+ T cells
CD8-Positive T-Lymphocytes - drug effects
CD8-Positive T-Lymphocytes - immunology
Cell Adhesion - drug effects
Cell Communication - drug effects
Cell Line, Tumor
Disease Models, Animal
exosome
Exosomes - drug effects
Exosomes - metabolism
Exosomes - ultrastructure
extracellular vesicles
ICAM-1
immune suppression
Immunosuppression Therapy
Intercellular Adhesion Molecule-1 - metabolism
Interferon-gamma - pharmacology
Melanoma - pathology
Mice
Mice, Inbred C57BL
Neoplasm Proteins - metabolism
PD-L1
Protein Binding - drug effects
T-Lymphocytes - cytology
T-Lymphocytes - immunology
Up-Regulation - drug effects
Title ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression
URI https://dx.doi.org/10.1016/j.devcel.2022.01.002
https://www.ncbi.nlm.nih.gov/pubmed/35085484
https://www.proquest.com/docview/2623883018
https://pubmed.ncbi.nlm.nih.gov/PMC8881799
Volume 57
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ZSwMxEA4eCL6It_UoEXwN3TOJj1os1aovVulb2HSndAW3tYfov_G3-Muc2aNYFQRfFnY32Q0zyeSbzMXYCQVDuqAcgbs1iEB5VA3QkwLsqY59oIxxdKB_cyub98FVJ-wssHoZC0NulYXsz2V6Jq2LJ7WCmrVhktTucK0GoXaUR9EmuE0usmUP0S9O9uWz84fW9cyYIN2sgBq1F9ShjKDL3LxieOkC2SA8L8vfWZyv_LJD_USg3x0pv-xMjXW2VkBKfpaPeoMtQLrJVvIik29bjIo63qAKl8WIIL7kUdwHOiPjyZhHfDiCETxPE7Iic0SwHF4H48ETCFTWke0xb3-80-k-H0-HhdNsus3ajYt2vSmKSgqiG0h_IoJTq8IoVqgNWVywKoq9SDqBCmVX90BaF6SWEWlfPiqMtictKq4QxtK1PrjK32FL6SCFPcZ7lM6UTJm40gOASNOXusq30kpwem6FiZJ4ZpjnyzClI9mjyYltiNjGcQ0Su8JUSWEzx3eDIv2PnsclQwwuCaJElMJgOjYeQjqtUXLpCtvNGTQbi4-AFJW0AP87x7pZA0q3Pf8mTfpZ2m2tNaXP2__3iA_YKt1lPt_qkC1NRlM4QkgzsdViylYR1F-28HrZOf8E32j2gw
link.rule.ids 230,315,783,787,888,3515,27583,27938,27939,45677,45888
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3ZTuMwcMQhBC8I2Kssh5F4tZrTNo8sWlSg5YWCeLPiZiqCtGm3B4K_4Vv4sp3JUVEWCYnX2E6smcx9ARxyMaSP2pMkrVFGOuBpgIGS6I5MGiJ3jGOHfudSta6j89v4dgFO6loYTquseH_J0wtuXT1pVtBsDrOseUW0GsXG0wFXm5CYXIRl0gY0WWDLx79uLtqzYILyiwFqvF_ygbqCrkjzSvGhhxyDCIKif2flX3lHQv2vgb5NpHwlmU43YL1SKcVxeetNWMB8C1bKIZNPX4CHOnbIhCtqREi_FEl6h-wjE9lYJGI4whH-nWYcRRakwQp8HIwHf1CSsU5oT0X35Zm9-2I8HVZJs_lX6J7-7p60ZDVJQfYiFU5kdOR0nKSarCFHBKuTNEiUF-lY9UwflfNRGZWw9RWSwej6ypHhinGqfBeir8NvsJQPcvwBos_tTDmUSZQeISaG39TToVNOodf3GyBr4Nlh2S_D1olk97YEtmVgW8-3BOwG6BrCdg7vllj6BycPaoRYIgmGRJLjYDq2Aal0xhDnMg34XiJodpeQFFIy0iL67hzqZhu43fb8Sp7dFW23jTHcPm_70zfeh9VWt9O27bPLi5-wxitF_rfegaXJaIq7pN5M3F71-_4D_2n3dA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ICAM-1-mediated+adhesion+is+a+prerequisite+for+exosome-induced+T%C2%A0cell+suppression&rft.jtitle=Developmental+cell&rft.au=Zhang%2C+Wei&rft.au=Zhong%2C+Wenqun&rft.au=Wang%2C+Beike&rft.au=Yang%2C+Jiegang&rft.date=2022-02-07&rft.issn=1534-5807&rft.volume=57&rft.issue=3&rft.spage=329&rft.epage=343.e7&rft_id=info:doi/10.1016%2Fj.devcel.2022.01.002&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_devcel_2022_01_002
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1534-5807&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1534-5807&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1534-5807&client=summon